Beneficial effects of colchicine on 17α-ethynylestradiol-induced cholestasis in rats

Abstract

Colchicine (CAS 64-86-8) is considered to have a hepatoprotective effect and play a role in biliary excretion. 17a-Ethynyl-estradiol (EE) (5 mg/kg, subcutaneously, daily, for 5 days) causes intrahepatic cholestasis by reducing both the influx and efflux of bile acid in hepatocytes, resulting in a decrease in bile flow. The objective of this study was to evaluate whether colchicine has any effect on EE-induced cholestasis. The effects of colchicine treatment on EE-induced cholestasis in rats for 5 consecutive days were evaluated. The serum components and enzymatic activity were assayed. In addition, the bile flow and biliary excretion were determined. Furthermore, western blot analysis was used to measure the expression of farnesoid X receptor (FXR), bile salt export pump (BSEP), multidrug resistance-associated protein 2 (MRP2), and cholesterol 7α-hydroxylase (CYP7A1). Colchicine not only significantly inhibited the elevation of cholestasis-related serum components and enzyme activity but also significantly attenuated the decrease of the bile flow and biliary excretion. Colchicine also remarkably increased the hepatic expression of FXR, BSEP and MRP2, but decreased that of CYP7A1. Our data indicates that colchicine treatment attenuated EE-induced cholestasis in rats, most likely by promoting bile flow and biliary excretion, and reduced the synthesis of bile acids.

Key words

Bile salt export pump - CAS 64-86-8 - Cholestasis - Cholesterol 7α-hydroxylase - Colchicine - Farnesoid X receptor - Multidrug resistance-associated protein 2

• References

• 1 Schreiber AJ, Simon FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology. 1983; 3: 607-13
• 2 Gumucio JJ, Valdivieso VD. Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology. 1971; 61: 339-44
• 3 Crocenzi FA, Sanchez Pozzi EJ, Pellegrino JM, Favre CO, Rodriguez Garay EA, Mottino AD, et al. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology. 2001; 34: 329-39
• 4 Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology. 2000; 118: 163-72
• 5 Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology. 1997; 113: 255-64
• 6 Le Marchand Y, Singh A, Assimacopoulos-Jeannet F, Orci L, Rouiller C, feanrenaud B. A role for the microtubular system in the release of very low density lipoproteins by perfused mouse livers. J Biol Chem. 1973; 248: 6862-70
• 7 Lee YM, Kaplan MM. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Am J Gastroenterol. 2003; 98: 205-8
• 8 Muriel P, Rivera-Espinoza Y. Beneficial drugs for liver diseases. J Appl Toxicol. 2008; 28: 93-103
• 9 Malawista SE. Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effec-ts. Arthritis Rheum. 1968; 11: 191-7
• 10 Poo JL, Feldmann G, Moreau A, Gaudin C, Lebrec D. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol. 1993; 19: 90-4
• 11 Mourelle M, Meza MA. Colchicine prevents D-galactosamine-induced hepatitis. J Hepatol. 1989; 8: 165-72
• 12 Muriel P, Quintanar ME, Perez-Alvarez V. Effect of colchicine on acetaminophen-induced liver damage. Liver. 1993; 13: 217-21
• 13 Dubin M, Maurice M, Feldmann G, Erlinger S. Influence of colchicine and phalloidin on bile secretion and hepatic ultra-structure in the rat. Possible interaction between microtubules and microfilaments. Gastroenterology. 1980; 79: 646-54
• 14 Barnwell SG, Lowe PJ, Coleman R. The effects of colchicine on secretion into bile of bile salts, phospholipids, cholesterol and plasma membrane enzymes: bile salts are secreted unaccompanied by phospholipids and cholesterol. Biochem J. 1984; 220: 723-31
• 15 Crawford JM, Berken CA, Gollan JL. Role of the hepatocyte microtubular system in the excreti-on of bile salts and biliary lipid: implications for intracellular vesicular transport. J Lipid Res. 1988; 29: 144-56
• 16 Barnwell SG, Yousef IM, Tuchweber B. The effect of colchicine on the development of lithochol-ic acid-induced cholestasis. A study of the role of microtubules in intracellular cholesterol transport. BiochemJ. 1986; 236: 345-50
• 17 Takikawa H, Sano N, Yamazaki R, Yamanaka M. Colchicine inhibits lithocholate-3-O-glucuroni-de-induced cholestasis in rats. J Hepatol. 1995; 22: 88-93
• 18 Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidi-zed glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969; 27: 502-22
• 19 Koopen NR, Wolters H, Havinga R, Vonk RJ, Jansen PL, Muller M et al. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat. Hepatology. 1998; 27: 537-545
• 20 Ruiz ML, Villanueva SS, Luquita MG, Ikushiro S, Mottino AD, Catania VA. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2. Drug Metab Dispos. 2007; 35: 2060-6
• 21 Sanchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG et al. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. J Pharmacol Exp Ther. 2003; 306: 279-86
• 22 Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology. 1991; 14: 551-66
• 23 Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003; 83: 633-71
• 24 Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem. 1998; 273: 10046-50
• 25 Rebbeor JF, Connolly GC, Ballatori N. Inhibition of Mrp2-and Ycflp-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2. Biochim Biophys Acta. 2002; 1559: 171-8
• 26 Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bi-le salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem. 2001; 276: 28857-65
• 27 Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive an-drostane receptor. J Biol Chem. 2002; 277: 2908-15
• 28 Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 2000; 6: 517-26
• 29 Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 2000; 6: 507-15
• 30 Denson IA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology. 2001; 121: 140-7
• 31 Zimmer V, Mullenbach R, Simon E, Bartz C, Matern S, Lammert F. Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int. 2009; 29: 1286-8
• 32 Van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology. 2007; 133: 507-16
• 33 Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G1124-30
• 34 Aoyama N, Ohya T, Chandler K, Gresky S, Holzbach RT. Transcellular transport of organic anio-ns in the isolated perfused rat liver: the differential effects of monensin and colchicine. Hepatology. 1991; 14: 1-9
• 35 Tachizawa H, Sano N, Takikawa H. Effects of colchicine on the maximum biliary excretion of cholephilic compounds in rats. J Gastroenterol Hepatol. 2004; 19: 1016-22
• 36 Takikawa H, Sano N, Akimoto K, Ogasawara T, Yamanaka M. Effects of colchicine and phenothiazine on biliary excretion of organic anions in rats. J Gastroenterol Hepatol. 1998; 13: 427-32